Home/Filings/4/0001415889-23-014357
4//SEC Filing

Kerr Douglas 4

Accession 0001415889-23-014357

CIK 0001733294other

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 6:00 PM ET

Size

8.5 KB

Accession

0001415889-23-014357

Insider Transaction Report

Form 4
Period: 2023-10-15
Kerr Douglas
CHIEF MEDICAL OFFICER
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2023-10-157,4377,437 total
    Common Stock (7,437 underlying)
  • Tax Payment

    Common Stock

    2023-10-15$3.24/sh2,183$7,073370,404 total
  • Exercise/Conversion

    Common Stock

    2023-10-15+7,437372,587 total
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of the company's common stock.
  • [F2]On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

Issuer

Generation Bio Co.

CIK 0001733294

Entity typeother

Related Parties

1
  • filerCIK 0001814189

Filing Metadata

Form type
4
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 6:00 PM ET
Size
8.5 KB